keyword
https://read.qxmd.com/read/38628772/efficacy-and-safety-of-ibrexafungerp-in-the-treatment-of-vulvovaginal-candidiasis-a-meta-analysis-of-randomized-controlled-trials
#21
JOURNAL ARTICLE
Rong He, Fei Lin, Bin Yu, Ling Huang
BACKGROUND: This study aims to evaluate the efficacy and safety associated with ibrexafungerp in the treatment of vulvovaginal candidiasis infection patients. METHODS: We conducted a comprehensive search of the PubMed, Embase, Cochrane Library, and Clinical Trials databases up to December 25, 2022. The primary outcomes were clinical cure rate and mycological eradication rate, whereas the secondary outcomes were the risk of an adverse events. RESULTS: In total of four studies encompassing 880 patients diagnosed with vulvovaginal candidiasis (VVC) were included in the analysis...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38628575/analysis-of-patient-safety-event-report-categories-at-one-large-academic-hospital
#22
JOURNAL ARTICLE
Cody Mitchell, Logan Butler, Alexa D Holloway, Jin H Ra, Karthik Adapa, Caprice Greenberg, Lawrence B Marks, Thomas Ivester, Lukasz Mazur
Given the persistent safety incidents in operating rooms (ORs) nationwide (approx. 4,000 preventable harmful surgical errors per year), there is a need to better analyze and understand reported patient safety events. This study describes the results of applying the Team Strategies and Tools to Enhance Performance and Patient Safety (TeamSTEPPS) supported by the Teamwork Evaluation of Non-Technical Skills (TENTS) instrument to analyze patient safety event reports at one large academic medical center. Results suggest that suboptimal behaviors stemming from poor communication, lack of situation monitoring, and inappropriate task prioritization and execution were implicated in most reported events...
2024: Front Health Serv
https://read.qxmd.com/read/38628463/medication-deprescribing-in-patients-receiving-hemodialysis-a-prospective-controlled-quality-improvement-study
#23
JOURNAL ARTICLE
Émilie Bortolussi-Courval, Tiina Podymow, Marisa Battistella, Emilie Trinh, Thomas A Mavrakanas, Lisa McCarthy, Joseph Moryousef, Ryan Hanula, Jean-François Huon, Rita Suri, Todd C Lee, Emily G McDonald
RATIONALE & OBJECTIVE: Patients treated with dialysis are commonly prescribed multiple medications (polypharmacy), including some potentially inappropriate medications (PIMs). PIMs are associated with an increased risk of medication harm (eg, falls, fractures, hospitalization). Deprescribing is a solution that proposes to stop, reduce, or switch medications to a safer alternative. Although deprescribing pairs well with routine medication reviews, it can be complex and time-consuming...
May 2024: Kidney medicine
https://read.qxmd.com/read/38628430/patient-controlled-subcutaneous-analgesia-with-hydromorphone-versus-oral-oxycontin-for-opioid-titration-of-cancer-pain-a-prospective-multicenter-randomized-trial
#24
JOURNAL ARTICLE
Xiaoguang Xiao, Jianhai Sun, Dongsheng Zhang, Linjun Li, Haibo Zhou, Yongjun Li, Quan Li, Zhongshi He, Yang Fu, Qiwen Duan, Guping Zheng, Ze Tang, Qian Chu, Yuan Chen
BACKGROUND: Studies have shown that oral oxycontin tablets can be used for opioid titration. The European Society for Medical Oncology (ESMO) guidelines for adult cancer pain recommend opioid titration through the parenteral route, usually the intravenous or subcutaneous route. Patient-controlled subcutaneous analgesia (PCSA) with hydromorphone needs further evaluation for opioid titration. This prospective multicenter study was designed to compare the efficacy and safety of hydromorphone PCSA with oral oxycontin tablets for opioid titration of cancer pain...
2024: Journal of Pain Research
https://read.qxmd.com/read/38628429/the-efficacy-of-neuromodulation-interventions-for-chemotherapy-induced-peripheral-neuropathy-a-systematic-review-and-meta-analysis
#25
REVIEW
Runbing Xu, Changhe Yu, Xinyu Zhang, Yipin Zhang, Mengfei Li, Bei Jia, Shiyan Yan, Miao Jiang
PURPOSE: To determine the efficacy and safety of a neuromodulation intervention regimen in the treatment of chemotherapy-induced peripheral neuropathy (CIPN). PATIENTS AND METHODS: Systematic searches were conducted in seven English databases. Randomized controlled trials of all neuromodulation interventions (both invasive and non-invasive) for the treatment of CIPN were selected. Group comparisons of differences between interventions and controls were also made...
2024: Journal of Pain Research
https://read.qxmd.com/read/38628412/teprotumumab-in-thyroid-eye-disease
#26
JOURNAL ARTICLE
Hila Goldberg, Amina I Malik
Thyroid eye disease (TED) is an inflammatory condition involving the periocular and orbital soft tissues, affecting most commonly patients with hyperthyroid disorders. Traditional treatments used for the active phase of the disease range from conservative lubrication for mild symptoms to systemic immunomodulating drugs for moderate-to-severe symptoms. Teprotumumab (Tepezza) is a monoclonal antibody with an inhibitory effect on insulin-like growth factor 1 and is the first Food and Drug Administration (FDA) approved targeted medical therapy for reducing the inflammatory signs and symptoms associated with TED...
2024: Saudi Journal of Ophthalmology: Official Journal of the Saudi Ophthalmological Society
https://read.qxmd.com/read/38628396/the-efficacy-and-safety-of-vonoprazan-in-quadruple-therapy-for-helicobacter-pylori-eradication-a-comparative-study
#27
JOURNAL ARTICLE
Xiaoduan Zhuang, Huiyue Jiang, Dandan Jin, Meiling Sun, Zhenwu Wang, Xinying Wang
BACKGROUND: The efficacy and optimal dose of the new acid-suppressant vonoprazan (VPZ) for quadruple therapy remain uncertain. This study aimed to compare the efficacy and safety of 20 mg VPZ daily (VOD) and 20 mg VPZ twice daily (VTD) with a proton pump inhibitor (PPI) twice daily in quadruple therapy. METHODS: We retrospectively analyzed the data of 954 patients treated with quadruple therapy to eradicate Helicobacter pylori . Eradication rates and adverse events were compared between the VOD and VTD groups, and between the VOD and PPI groups...
2024: Gastroenterology Report
https://read.qxmd.com/read/38628292/bone-anchored-prostheses-for-transfemoral-amputation-a-systematic-review-of-outcomes-complications-patient-experiences-and-cost-effectiveness
#28
Mayank Rehani, Tania Stafinski, Jeff Round, C Allyson Jones, Jacqueline S Hebert
INTRODUCTION: Bone-anchored prostheses (BAP) are an advanced reconstructive surgical approach for individuals who had transfemoral amputation and are unable to use the conventional socket-suspension systems for their prostheses. Access to this technology has been limited in part due to the lag between the start of a new procedure and the availability of evidence that is required before making decisions about widespread provision. This systematic review presents as a single resource up-to-date information on aspects most relevant to decision makers, i...
2024: Front Rehabil Sci
https://read.qxmd.com/read/38628258/staff-supported-community-outings-among-forensic-mental-health-patients-patient-characteristics-rehabilitative-goals-and-the-absence-of-adverse-outcomes
#29
JOURNAL ARTICLE
Christian Farrell, Karen L Petersen, Peri Hanzouli, Tonia L Nicholls
Mental health professionals are tasked with making difficult clinical decisions in treatment settings. In the forensic system, decision making regarding staff supervised community outings (SSCOs) provides a significant challenge due to the need to balance patient liberties, mental health recovery, and public safety. This study explored the characteristics and rehabilitative nature of SSCOs, characteristics of patients attending SSCOs, and any adverse events that occurred during the outings. Employing a cross-sectional design, 110 patients who participated in SSCOs over a one-year period from a Canadian Forensic Psychiatric Hospital were included...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38628176/safety-assessment-of-a-proprietary-fermented-soybean-solution-symbiota%C3%A2-as-an-ingredient-for-use-in-foods-and-dietary-supplements-non-clinical-studies-and-a-randomized-trial
#30
JOURNAL ARTICLE
Chien-Min Hung, Wen-Cheng Chu, Wen-Yen Huang, Pei-Jung Lee, Wen-Chih Kuo, Cheng-Yu Hou, Chia-Chun Yang, Ai-Jen Yang, Wei-Kai Wu, Ming-Liang Kuo, Ming-Shiang Wu, Wan-Jiun Chen
A safety evaluation was performed of Symbiota®, which is made by a proprietary anaerobic fermentation process of soybean with multistrains of probiotics and a yeast. The battery of genotoxicity studies showed that Symbiota® has no genotoxic effects. Safety and tolerability were further assessed by acute or repeated dose 28- and 90-day rodent studies, and no alterations in clinical observations, ophthalmological examination, blood chemistry, urinalysis, or hematology were observed between the control group and the different dosing groups (1...
April 2024: Food Science & Nutrition
https://read.qxmd.com/read/38627846/effectiveness-and-safety-of-manual-therapy-when-compared-with-oral-pain-medications-in-patients-with-neck-pain-a-systematic-review-and-meta-analysis
#31
REVIEW
Joshua Makin, Lauren Watson, Dimitra V Pouliopoulou, Taylor Laframboise, Bradley Gangloff, Ravinder Sidhu, Jackie Sadi, Pulak Parikh, Anita Gross, Pierre Langevin, Heather Gillis, Pavlos Bobos
BACKGROUND: This systematic review and meta-analysis seeks to investigate the effectiveness and safety of manual therapy (MT) interventions compared to oral pain medication in the management of neck pain. METHODS: We searched from inception to March 2023, in Cochrane Central Register of Controller Trials (CENTRAL), MEDLINE, EMBASE, Allied and Complementary Medicine (AMED) and Cumulative Index to Nursing and Allied Health Literature (CINAHL; EBSCO) for randomized controlled trials that examined the effect of manual therapy interventions for neck pain when compared to medication in adults with self-reported neck pain, irrespective of radicular findings, specific cause, and associated cervicogenic headaches...
April 16, 2024: BMC Sports Science, Medicine and Rehabilitation
https://read.qxmd.com/read/38627798/efficacy-and-safety-of-antibiotics-for-treatment-of-leptospirosis-a-systematic-review-and-network-meta-analysis
#32
JOURNAL ARTICLE
Zhenhua Ji, Miaomiao Jian, Xuan Su, Yingyi Pan, Yi Duan, Weijie Ma, Lei Zhong, Jiaru Yang, Jieqin Song, Xinya Wu, Li Gao, Weijiang Ma, Jing Kong, Bingxue Li, Jinjing Chen, Meixiao Liu, Yuxin Fan, Li Peng, Yan Dong, Fukai Bao, Aihua Liu
BACKGROUND: Leptospirosis, an important zoonotic bacterial disease, commonly affects resource-poor populations and results in significant morbidity and mortality worldwide. The value of antibiotics in leptospirosis remains unclear, as evidenced by the conflicting opinions published. METHODS: We conducted a search in the PubMed, Web of Science, and Cochrane Library databases for studies. These studies included clinical trials and retrospective studies that evaluated the efficacy or safety of antibiotics for leptospirosis treatment...
April 16, 2024: Systematic Reviews
https://read.qxmd.com/read/38627795/implementation-of-an-antimicrobial-stewardship-program-for-urinary-tract-infections-in-long-term-care-facilities-a-cluster-controlled-intervention-study
#33
JOURNAL ARTICLE
Elisabeth König, Lisa Kriegl, Christian Pux, Michael Uhlmann, Walter Schippinger, Alexander Avian, Robert Krause, Ines Zollner-Schwetz
BACKGROUND: Widespread inappropriate use of antimicrobial substances drives resistance development worldwide. In long-term care facilities (LTCF), antibiotics are among the most frequently prescribed medications. More than one third of antimicrobial agents prescribed in LTCFs are for urinary tract infections (UTI). We aimed to increase the number of appropriate antimicrobial treatments for UTIs in LTCFs using a multi-faceted antimicrobial stewardship intervention. METHODS: We performed a non-randomized cluster-controlled intervention study...
April 16, 2024: Antimicrobial Resistance and Infection Control
https://read.qxmd.com/read/38627684/haic-combined-with-lenvatinib-plus-pd-1-versus-lenvatinib-plus-pd-1-in-patients-with-high-risk-advanced-hcc-a-real-world-study
#34
JOURNAL ARTICLE
Xu Chang, Xinge Li, Peng Sun, Zhenfeng Li, Pengfei Sun, Shangkun Ning
BACKGROUND: The treatment of hepatocellular carcinoma (HCC) patients exhibiting high-risk characteristics (Vp4, and/or bile duct invasion, and/or tumor occupancy ≥ 50%) lacks standardized approaches and yields unfavorable results. This study endeavors to evaluate the safety, efficacy, and prognostic impacts of employing hepatic arterial infusion chemotherapy (HAIC), lenvatinib, and humanized programmed death receptor-1 (PD-1) in the treatment of high-risk HCC patients...
April 16, 2024: BMC Cancer
https://read.qxmd.com/read/38627638/rimegepant-orally-disintegrating-tablet-75%C3%A2-mg-for-acute-treatment-of-migraine-in-adults-from-china-a-subgroup-analysis-of-a-double-blind-randomized-placebo-controlled-phase-3-clinical-trial
#35
RANDOMIZED CONTROLLED TRIAL
Shengyuan Yu, Aihong Guo, Zhen Wang, Jianguang Liu, Ge Tan, Qian Yang, Mingjie Zhang, Hasiyeti Yibulaiyin, Huisheng Chen, Yongbo Zhang, Robert Croop, Yanhui Sun, Yu Liu, Qian Zhao, Zhihong Lu
BACKGROUND: Rimegepant orally disintegrating tablet (ODT), an oral small-molecule calcitonin gene-related peptide receptor antagonist, is indicated for acute and preventive treatment of migraine in the United States and other countries. Previously, a large clinical trial assessed the efficacy and safety of rimegepant ODT 75 mg for the acute treatment of migraine in adults living in China or South Korea. A post hoc subgroup analysis of this trial was performed to evaluate the efficacy and safety of rimegepant for acute treatment of migraine in adults living in China...
April 16, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38627464/ppar-agonists-as-add-on-treatment-with-metformin-in-management-of-type-2-diabetes-a-systematic-review-and-meta-analysis
#36
JOURNAL ARTICLE
Saif Alnuaimi, Tea Reljic, Fatima S Abdulla, Hamda Memon, Sarah Al-Ali, Teagen Smith, Fadila Serdarevic, Zelija Velija Asimi, Ambuj Kumar, Sabina Semiz
The combination of metformin and the peroxisome proliferator-activated receptors (PPAR) agonists offers a promising avenue for managing type 2 diabetes (T2D) through their potential complementary mechanisms of action. The results from randomized controlled trials (RCT) assessing the efficacy of PPAR agonists plus metformin versus metformin alone in T2D are inconsistent, which prompted the conduct of the systematic review and meta-analysis. We searched MEDLINE and EMBASE from inception (1966) to March 2023 to identify all RCTs comparing any PPAR agonists plus metformin versus metformin alone in T2D...
April 16, 2024: Scientific Reports
https://read.qxmd.com/read/38627377/neoadjuvant-tislelizumab-plus-stereotactic-body-radiotherapy-and-adjuvant-tislelizumab-in-early-stage-resectable-hepatocellular-carcinoma-the-notable-hcc-phase-1b-trial
#37
JOURNAL ARTICLE
Zhongchao Li, Jing Liu, Bo Zhang, Jinbo Yue, Xuetao Shi, Kai Cui, Zhaogang Liu, Zhibin Chang, Zhicheng Sun, Mingming Li, Yue Yang, Zhao Ma, Lei Li, Chengsheng Zhang, Pengfei Sun, Jingtao Zhong, Lei Zhao
Notable-HCC (NCT05185531) is a phase 1b trial, aiming to evaluate the safety and preliminary effectiveness of neoadjuvant PD-1 blockade plus stereotactic body radiotherapy (SBRT) in early-stage resectable hepatocellular carcinoma (HCC). Twenty patients with HCC of BCLC stage 0-A received 3 <mml:math xmlns:mml="https://www.w3.org/1998/Math/MathML"><mml:mo>×</mml:mo></mml:math> Gy SBRT and two cycles of tislelizumab, an anti-PD-1 monoclonal antibody before the curative HCC resection...
April 16, 2024: Nature Communications
https://read.qxmd.com/read/38627366/phase-ii-study-of-novel-orally-pi3k%C3%AE-%C3%AE-inhibitor-tq-b3525-in-relapsed-and-or-refractory-follicular-lymphoma
#38
JOURNAL ARTICLE
Huaqing Wang, Jifeng Feng, Yanyan Liu, Zhengzi Qian, Da Gao, Xuehong Ran, Hui Zhou, Lihong Liu, Binghua Wang, Meiyun Fang, Hebing Zhou, Zhenqian Huang, Shi Tao, Zhuowen Chen, Liping Su, Hang Su, Yu Yang, Xiaobao Xie, Huijing Wu, Ping Sun, Guoyu Hu, Aibin Liang, Zhiming Li
This registration study assessed clinical outcomes of TQ-B3525, the dual phosphatidylinositol-3-kinase (PI3K) α/δ inhibitor, in relapsed and/or refractory follicular lymphoma (R/R FL). This phase II study (ClinicalTrials.gov NCT04324879. Registered March 27, 2020) comprised run-in stage and stage 2. R/R FL patients after ≥2 lines therapies received oral 20 mg TQ-B3525 once daily in a 28-day cycle until intolerable toxicity or disease progression. Primary endpoint was independent review committee (IRC)-assessed objective response rate (ORR)...
April 17, 2024: Signal Transduction and Targeted Therapy
https://read.qxmd.com/read/38627317/efficacy-and-safety-analysis-of-immunotherapy-in-non-small-cell-lung-cancer-patients-with-met-alterations
#39
JOURNAL ARTICLE
Yanhua Wang, Jingwen Wei, Manyi Xu, Jing Xiang, Keda Shao, Yue Hao, Zhengbo Song
BACKGROUND: Mesenchymal epithelial transition factor (MET) is a rare oncologic driver gene, and information on immunotherapy for non-small cell lung cancer (NSCLC) patients with this driver gene is limited. Here we evaluate the efficacy and safety of immune checkpoint inhibitors (ICI) under different therapeutic regimen for NSCLC patients with MET alterations. METHODS: From June 2019 to December 2023, we assessed the efficacy and toxicity of ICIs in 42 NSCLC patients with MET alterations...
April 16, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38627298/safety-of-masitinib-in-patients-with-neurodegenerative-diseases-a-meta-analysis-of-randomized-controlled-trials
#40
JOURNAL ARTICLE
Abdullah Ashraf Hamad, Basma Ehab Amer
OBJECTIVES: This meta-analysis aimed to examine the safety of masitinib in patients with neurodegenerative diseases. METHODS: We considered randomized controlled trials (RCTs) comparing different doses of masitinib versus placebo. We performed our analysis using the R (v.4.3.0) programming language and the incidence of adverse events was pooled using risk ratio (RR) and 95% confidence interval (CI). RESULTS: We included five RCTs, focusing on multiple sclerosis (MS), Alzheimer's disease (AD), and amyotrophic lateral sclerosis...
April 17, 2024: Neurological Sciences
keyword
keyword
45557
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.